2-[[2-chloro-6-(3,5-dimethylpyrazol-1-yl)-4-pyridinyl]oxy]-9-pyridin-2-ylcarbazole
C27H20ClN5O — CID 155675530
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-chloro-6-(3,5-dimethylpyrazol-1-yl)-4-pyridinyl]oxy]-9-pyridin-2-ylcarbazole
2-[[2-chloro-6-(3,5-dimethylpyrazol-1-yl)-4-pyridinyl]oxy]-9-pyridin-2-ylcarbazole (PubChem CID 155675530) has the molecular formula C27H20ClN5O and a molecular weight of 465.94 g/mol. Its IUPAC name is 2-[[2-chloro-6-(3,5-dimethylpyrazol-1-yl)-4-pyridinyl]oxy]-9-pyridin-2-ylcarbazole.
Molecular Properties
| Compound Name | 2-[[2-chloro-6-(3,5-dimethylpyrazol-1-yl)-4-pyridinyl]oxy]-9-pyridin-2-ylcarbazole |
|---|---|
| PubChem CID | 155675530 |
| Molecular Formula | C27H20ClN5O |
| Molecular Weight | 465.94 g/mol |
| Exact Mass | 465.14 |
| IUPAC Name | 2-[[2-chloro-6-(3,5-dimethylpyrazol-1-yl)-4-pyridinyl]oxy]-9-pyridin-2-ylcarbazole |
| SMILES | Cc1cc(C)n(-c2cc(Oc3ccc4c5ccccc5n(-c5ccccn5)c4c3)cc(Cl)n2)n1 |
| InChI | InChI=1S/C27H20ClN5O/c1-17-13-18(2)33(31-17)27-16-20(15-25(28)30-27)34-19-10-11-22-21-7-3-4-8-23(21)32(24(22)14-19)26-9-5-6-12-29-26/h3-16H,1-2H3 |
| InChIKey | YEAVNHHUGGHGKT-UHFFFAOYSA-N |
| XLogP | 6.82 |
| TPSA | 57.76 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.94 |
| LogP ≤ 5 | 6.82 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155675530 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.